TNFSF10 and cancer: Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), which binds to the overexpressed death receptor 4 and 5, exhibited limited efficacy as a monotherapy in resistant cancer cells[95-98].